HELSINKI, Finland & MUNICH, Germany--(BUSINESS WIRE)--Inveni Capital, a newly formed Finnish-German venture capital company, announces the first closing of its Inveni Life Sciences Fund I of over €20 million. The ultimate size of the fund is targeted at €50 to 70 million. Investors in the fund include Finnish Industry Investment Ltd as the biggest single investor, The University of Helsinki and several private investors and funds.
